04 July, 2022
AOTMiT Webinar – Increase in expenditure on neonatal care. New tariffs and settlement conditions
more...29 June, 2022
Communication – acquisition of data Bone marrow biopsy (specialist outpatient care)
more...27 June, 2022
Summary of information indicated by applicants to be kept confidential in selected areas of the documentation published by AOTMiT (applicant’s analyses, verification analyses, positions of the Transparency Council, recommendations of the President) in the evaluation of reimbursement applications for the year 2021 and Q1 2022.
more...27 June, 2022
Opinion of the Transparency Council – health policy programme of Piaseczno Poviat in the scope of prostate cancer prevention
more...27 June, 2022
Opinion of the Transparency Council – amendments to PL B.59 on melanoma of the skin or mucous membranes
more...27 June, 2022
Opinion of the Transparency Council – health policy programme of the Municipality of Zgierz in the scope of prevention and correction of vision in children
more...23 June, 2022
Opinion of the Transparency Council – health policy programme for the residents of the Warmińsko-Mazurskie Voivodeship within the scope of support for diagnostics and treatment of infertility excluding the methods of medically assisted reproduction
more...23 June, 2022
Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of retinoblastoma or von Hippel-Lindau (VHL) disease” as a guaranteed health care service
more...23 June, 2022
Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of colorectal cancer or endometrial cancer” as a guaranteed health care service
more...23 June, 2022
Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of breast or ovarian cancer” as a guaranteed health care service
more...23 June, 2022
Position of the Transparency Council – qualifying the health care service “Colorectal cancer screening programme” as a guaranteed health care service
more...22 June, 2022
Recommendation of the President – on the legitimacy of qualifying the health care service “Care for families at high hereditary risk for retinoblastoma or von Hippel-Lindau disease (VHL)” – as a guaranteed outpatient specialised care service
more...22 June, 2022
Recommendation of the President – on the legitimacy of qualifying the health care service “Care for families at high hereditary risk for colorectal cancer or endometrial cancer – as a guaranteed outpatient specialised care service
more...22 June, 2022
Recommendation of the President – on the legitimacy of qualifying the health care service “Care for families at high hereditary risk for breast or ovarian cancer – as a guaranteed outpatient specialised care service
more...22 June, 2022